1. Covering the Bases in Cardioversion

2. Program Goals and Talking Points

3. Patient Case : Scenario 1

4. Patient Case: Scenario 2

5. Cardioversion and the Risk for Stroke

6. Asymptomatic Episodes

7. Endocardial Remodeling

8. Symptomatic vs Asymptomatic AF

9. REVEAL AF: AF Incidence by CHADS2 Subgroup

10. Selecting an Anticoagulant: Convenience Counts

11. Persistence of Anticoagulants Following AF

12. NOAC Dosing

13. Other factors to Consider

14. ENSURE-AF Study Design

15. ENSURE-AF: Event Rates

16. Advantages of Using NOACs During Cardioversion

17. ENSURE-AF: Event Rates By Age and Gender

18. Stroke Risk vs Bleeding Risk

19. Short Duration of AF May confer risk

20. Abbreviations

21. Abbreviations (cont)